echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Endocrine System > Human induced pluripotent stem cells differentiate into hypothalamic vasopressin neurons with minimal exogenous signals and partial transformation into a naïve state or treatable central diabetes insipidus

    Human induced pluripotent stem cells differentiate into hypothalamic vasopressin neurons with minimal exogenous signals and partial transformation into a naïve state or treatable central diabetes insipidus

    • Last Update: 2022-11-04
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    The hypothalamus plays an important role in maintaining physiological balance, one of which is the production and secretion of arginine vasopressin (AVP), which controls water balance
    .
    Familial neuropituitary diabetes insipidus (FNDI) is characterized by the degeneration of neurons in the hypothalamus leading to a gradual decrease
    in AVP secretion.
    Mutations in the AVP gene locus in FINDI patients have been identified, mostly in the region encoding the AVP vector protein, known as neuroprotein II (NPII).

    Therefore, the team used transgenic technology to obtain FNDI mice with the Cys98stop (formerly known as Cys67stop) mutation, which occurred in FNDI patients, for pathological analysis
    .

    In previous studies, the team used the Cys98stop-knock-in FNDI mouse model to find that endoplasmic reticulum (ER) stress caused by the accumulation of mutant proteins in ER may be related to
    FNDI pathology.
    However, further research is needed, including the use of human patient models, to investigate the overall pathological mechanism of
    FNDI.
    Research on FNDI in humans is technically limited because hypothalamic biopsies cannot be performed on living people, and loss of AVP neurons in human FNDI patients has only been
    reported in autopsy studies.
    Therefore, AVP neurons extracted from human FNDI-specific induced pluripotent stem cells (iPSCs) are a promising human model that can be used in pathological analysis and drug development
    .

    Research Objectives:

    The team induced differentiation from human FNDI disease-specific iPSCs to AVP neurons with minimal exogenous signals, as described previously described for miPSCs
    .
    To apply minimal exogenous signals to human iPSCs, the team focused on the differences
    in initial state between human iPSCs and mouse iPSCs.

    In vivo model studies in mice have shown that the accumulation of mutant AVP prehormones is associated
    with FNDI pathology.
    However, studying human FNDI pathology in vivo is technically challenging
    .
    Therefore, in vitro mannequins
    need to be developed.
    When exogenous signals are minimized in the early stages of in vitro differentiation, mouse embryonic stem cells (ESCs)/induced pluripotent stem cells (iPSCs) differentiate into AVP neurons while human ESCs/iPSCs die
    .

    Human ESC/iPSCs generally resemble mouse ectodermal stem cells (mEpiSC)
    compared to mouse ESCs.
    In this study, the team converted human FNDI-specific iPSCs
    via a naive conversion kit.
    While the conversion was partial, the study found improved
    cell survival with minimal exogenous signals and differentiation into hypothalamic beak organoids.
    Overall, this method provides a simple and direct direction of differentiation that can improve the efficiency of
    hypothalamic differentiation.

     

    References:

    Ozaki H, Suga H, Sakakibara M, Soen M, Miyake N, Miwata T, Taga S, Nagai T, Kano M, Mitsumoto K, Miyata T, Kobayashi T, Sugiyama M, Onoue T, Takagi H, Hagiwara D, Iwama S, Banno R, Iguchi G, Takahashi Y, Muguruma K, Inoue H, Arima H.
    Differentiation of human induced pluripotent stem cells into hypothalamic vasopressin neurons with minimal exogenous signals and partial conversion to the naive state.
    Sci Rep.
    2022 Oct 17; 12(1):17381.
    doi: 10.
    1038/s41598-022-22405-8.
    PMID: 36253431; PMCID: PMC9576732.

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.